Medical isotope development and supply opportunities in the 21st century

Research in extending medical isotopes for the diagnosis and treatment of numerous health maladies is hampered by outages and upsets in major supply sources. Investigations in cures for brain cancer ( 211 At), HIV/AIDS virus ( 213 Bi), and even bacterial vectors are either in reduced progress mode o...

Full description

Saved in:
Bibliographic Details
Published in:Journal of radioanalytical and nuclear chemistry 2009-10, Vol.282 (1), p.243-246
Main Authors: Troyer, G. L., Schenter, R. E.
Format: Article
Language:English
Subjects:
Chemistry
Chemistry and Materials Science
Diagnostic Radiology
Hadrons
Heavy Ions
Inorganic Chemistry
Nuclear Chemistry
Nuclear Physics
Physical Chemistry
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Research in extending medical isotopes for the diagnosis and treatment of numerous health maladies is hampered by outages and upsets in major supply sources. Investigations in cures for brain cancer ( 211 At), HIV/AIDS virus ( 213 Bi), and even bacterial vectors are either in reduced progress mode or have been cancelled until isotopes become available. Examples of several key radioactive medical isotopes include 99m Tc for diagnostics, 131 I for non-Hodgkin’s lymphoma and thyroid cancer, 225 Ac for acute myelogenous leukemia, and 67 Cu for lymphoma cancer. Possibilities for developing commercially viable sources using compact accelerators and next generation research and production reactors are discussed.
ISSN:0236-5731
1588-2780
DOI:10.1007/s10967-009-0267-4